Comparative analysis of dimethyl fumarate and teriflunomide in relapsing-remitting multiple sclerosis

被引：0
|
作者：
Mueller, J. [1 ,2 ,3 ]
Schaedelin, S. [4 ]
Benkert, P. [4 ]
Haenni, P. [5 ]
Schmid, J. [5 ]
Derfuss, T. [1 ,2 ,3 ]
Kuhle, J. [1 ,2 ,3 ]
Yaldizli, O. [1 ,2 ,3 ]
机构：
[1] Univ Hosp Basel, MS Ctr, Neurol Clin & Policlin, Basel, Switzerland
[2] Univ Hosp Basel, Res Ctr Clin Neuroimmunol & Neurosci Basel RC2NB, Basel, Switzerland
[3] Univ Basel, Basel, Switzerland
[4] Univ Hosp Basel, Clin Trial Unit, Basel, Switzerland
[5] Swiss Federat Common Tasks Hlth Insurances SVK, Solothurn, Switzerland
来源：
MULTIPLE SCLEROSIS JOURNAL | 2021年 / 27卷 / 2_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P819
引用
收藏
页码：676 / 676
页数：1
相关论文
共 50 条
  • [1] Comparative analysis of dimethyl fumarate and teriflunomide in relapsing-remitting multiple sclerosis
    Muller, Jannis
    Schadelin, Sabine
    Lorscheider, Johannes
    Benkert, Pascal
    Hanni, Peter
    Schmid, Jurg
    Kuhle, Jens
    Derfuss, Tobias
    Granziera, Cristina
    Yaldizli, Ozgur
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 (12) : 3809 - 3818
  • [2] Effectiveness of fingolimod, dimethyl fumarate and teriflunomide in relapsing-remitting multiple sclerosis: a comparative longitudinal study
    Kalincik, T.
    Spelman, T.
    Jokubaitis, V.
    Horakova, D.
    Havrdova, E.
    Izquierdo, G.
    Prat, A.
    Girard, M.
    Duquette, P.
    Lugaresi, A.
    Grammond, P.
    Alroughani, R.
    Lechner-Scott, J.
    Prevost, J.
    Terzi, M.
    Grand'Maison, F.
    Boz, C.
    Trojano, M.
    Van Wijmeersch, B.
    Pucci, E.
    Granella, F.
    Turkoglu, R.
    Sola, P.
    Ferraro, D.
    McCombe, P.
    Solaro, C.
    Van Pesch, V.
    Ozakbas, S.
    Slee, M.
    Spitaleri, D.
    Sanchez-Menoyo, J. L.
    Ampapa, R.
    Hodgkinson, S.
    Karabudak, R.
    Vucic, S.
    Butzkueven, H.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 325 - 327
  • [3] Comparative analysis of dimethyl fumarate and fingolimod in relapsing-remitting multiple sclerosis
    Lorscheider, Johannes
    Benkert, Pascal
    Lienert, Carmen
    Haenni, Peter
    Derfuss, Tobias
    Kuhle, Jens
    Kappos, Ludwig
    Yaldizli, Oezguer
    JOURNAL OF NEUROLOGY, 2021, 268 (03) : 941 - 949
  • [4] Comparable Efficacy and Safety of Teriflunomide versus Dimethyl Fumarate for the Treatment of Relapsing-Remitting Multiple Sclerosis
    Nehzat, Nasim
    Mirmosayyeb, Omid
    Barzegar, Mahdi
    Vosoughi, Reza
    Fazeli, Erfane
    Shaygannejad, Vahid
    NEUROLOGY RESEARCH INTERNATIONAL, 2021, 2021
  • [5] Comparative analysis of fingolimod versus teriflunomide in relapsing-remitting multiple sclerosis
    Boz, Cavit
    Terzi, Murat
    Ozer, Bilge
    Turkoglu, Recai
    Karabudak, Rana
    Efendi, Husnu
    Soysal, Aysun
    Sevim, Serhan
    Altintas, Ayse
    Kurne, Asli
    Akcali, Aylin
    Akman, Gulsen
    Yuceyar, Nur
    Balci, Belgin Petek
    Ekmekci, Ozgul
    Karahan, Serap Zengin
    Demirkiran, Meltem
    Altunrende, Burcu
    Turan, Omer Faruk
    GozubatikCelik, Gokcen
    Kale, Nilufer
    Koseoglu, Mesrure
    Ozakbas, Serkan
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 36
  • [6] COST-MINIMIZATION ANALYSIS OF TERIFLUNOMIDE AND DIMETHYL FUMARATE FOR TREATMENT OF RELAPSING-REMITTING FORMS OF MULTIPLE SCLEROSIS IN ITALY
    Stanisic, S.
    Bergamaschi, R.
    Berto, P.
    Di Procolo, P.
    Marocco, A.
    Morawski, J.
    VALUE IN HEALTH, 2018, 21 : S341 - S341
  • [7] Dimethyl Fumarate or Teriflunomide for Relapsing-Remitting Multiple Sclerosis: A Meta-analysis of Post-marketing Studies
    Prosperini, Luca
    Haggiag, Shalom
    Ruggieri, Serena
    Tortorella, Carla
    Gasperini, Claudio
    NEUROTHERAPEUTICS, 2023, 20 (05) : 1275 - 1283
  • [8] Dimethyl fumarate in the treatment of relapsing-remitting multiple sclerosis: an overview
    Bomprezzi, Roberto
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2015, 8 (01) : 20 - 30
  • [9] Comparative analysis of dimethyl fumarate and fingolimod in relapsing–remitting multiple sclerosis
    Johannes Lorscheider
    Pascal Benkert
    Carmen Lienert
    Peter Hänni
    Tobias Derfuss
    Jens Kuhle
    Ludwig Kappos
    Özgür Yaldizli
    Journal of Neurology, 2021, 268 : 941 - 949
  • [10] COST-UTILITY ANALYSIS OF DIMETHYL FUMARATE VERSUS FINGOLIMOD AND TERIFLUNOMIDE IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN COLOMBIA
    Ordonez, J.
    Serafini, P.
    Machado, M.
    VALUE IN HEALTH, 2016, 19 (07) : A434 - A434
12345